跳至主要内容
临床试验/IRCT20120415009472N19
IRCT20120415009472N19招募中2 期

Effects of Rosemary (Rosmarinus officinalis) Leaves Powder And Weight Reducing Diet on Hs-CRP, MDA, TAC, Blood Pressure, Anthropometric measurement, Quality of life, Sleep and Appetite in Patients with Non-Alcoholic Fatty Liver Disease

Vice-chancellor for research Iran University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • Desire to participate in studying and signing consent
  • Evidence of hepatic steatosis in liver ultrasonography (grade 1 to 3 fatty liver)
  • Increased liver enzymes than normal (AST> 38 and ALT> 40 for men and AST> 31 and ALT> 33 for women)
  • BMI in the range of 25-40 kg / m2
  • aged between 20 and 65 years

排除标准

  • Unwillingness to participate in the study
  • Secondary conditions that lead to hepatic steatosis, including: alcohol consumption, hereditary disorders affecting liver status (hemochromatosis and Wilson's disease), and known autoimmune disease
  • Other chronic and acute liver diseases and disorders such as hepatitis, cirrhosis, celiac disease, diabetes, thyroid disorders, cardiovascular, renal, pulmonary and inflammatory diseases (rheumatism)
  • History of taking hepatotoxic drugs (methotrexate, amiodarone, tamoxifen, nifedipine, corticosteroids, valproate and antiviral drugs) as well as anticoagulants such as aspirin
  • Use of any nutritional supplement in the past two months
  • Use of weight-loss drugs over the past two months
  • Having a severe weight loss diet (more than 10% weight loss) over the past three months
  • Pregnancy or lactation

研究者

发起方
Vice-chancellor for research Iran University of Medical Sciences

相似试验